Brand Name Drug Giant Beats Wall Street Expectations After Price Hikes on Treatments for Osteoporosis, Heart Conditions and Cancer Yet another Big Pharma giant proved what we already know – that hiking prices on American patients continues to be a profitable practice for the pharmaceutical industry. On Thursday, brand name drug company Amgen announced it […]
Brand Name Giants Keep Good Times Rolling Thanks to Series of Price Hikes on American Patients New fourth quarter earnings reports released this week from brand name giants Eli Lilly, Roche, Novartis and Pfizer demonstrate that out-of-control prescription drug prices paired with repeated price hikes continue to support big time profits for Big Pharma. All […]
Prescription Drug Price Hikes Help Fuel Massive 32 Percent Boost to Profits For Big Pharma Giant As millions of Americans struggle to afford the medications they need, the first earnings report from a Big Pharma giant demonstrates the industry continues to rake in sky-high profits by shamelessly hiking prices. Just yesterday, brand name drug […]
Editorial Boards, Lawmakers and More Reiterate Need for Market-Based Solutions to Out-of-Control Prescription Drug Prices in 2020 Right on cue, Big Pharma kicked off the New Year by raising prices on 2,167 prescription drugs in the first week of 2020. The new round of price hikes have added to the momentum to pass bipartisan market-based […]
News from First Weeks of New Year Underscores Urgent Need for Action in Congress In case you missed it, Big Pharma has hiked prices on 2,167 prescription drugs so far this year – proving once again that without legislative action, brand name drug makers will continue to price-gouge American patients. Among the companies hiking prices […]
Drug Makers, Including Brand Name Giants Like Pfizer, Increase Prices on More Than 200 Prescription Drugs Despite Mounting Crisis of Affordability For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Thursday in response to a new analysis which found drug makers, including brand […]
CMS Report Demonstrates Impact of Out-of-Control Launch Prices and Tactics That Prevent Patients From Accessing Affordable Alternatives In case you missed it, according to the Centers for Medicare and Medicaid Services’ (CMS) annual report on health care spending, the pricing practices and anti-competitive tactics of Big Pharma kept drug costs rising last year — even […]
Analysis of Multiple Sclerosis Drug Pricing Undercuts Drug Makers’ Bogus “Innovation” Rhetoric A new study published in the American Academy of Neurology finds the staggering price of medications to treat multiple sclerosis (MS), a rare neurological disorder, is driven largely by profit motivations – not research and development (R&D). These findings undermine Big Pharma’s bogus […]
Political Courage Needed to Deliver on Drug Prices By Lauren Aronson Real Clear Health November 22, 2019 The egregious pricing behavior of pharmaceutical giants has sparked a crisis of prescription drug affordability in America. Now, after months of dedicated attention to this crisis and unprecedented momentum for action in Washington, the pathway to results for […]
Nine in Ten Surveyed Adults Believe Rx Prices “Much Higher” Or “Somewhat Higher” Than Reasonable A new Gallup survey demonstrates the rising toll of out-of-control prescription drug prices on American patients and families. According to the survey, nearly 23 percent of Americans, approaching 58 million U.S. adults, say they have been unable to afford drugs […]